The tool aims to discern which patients are likely to get even sicker and which really ought to get out of the hospital waiting room, go home and rest.
While the drug aims to help clear the virus faster and reduce acute symptoms, there isn't a clear connection between that reduction and fewer instances of Long-COVID, one study has found.
These rare infections can progress quickly leading to serious and life threatening infections, including sepsis, soft-tissue necrosis, toxic shock syndrome and meningitis.
Annual data from the Public Health Agency of Canada shows a record number of bacterial infections that have been deadly in rare cases, especially among children.